Is Concurrent Chemoradiation the Treatment of Choice for All Patients with Stage III or IV Head and Neck Carcinoma?

Cancer

Volumn 100, Issue 6, 2004, Pages 1171-1178

  Garden, Adam S ^a,b   Asper, Joshua A ^a   Morrison, William H ^a   Schechter, Naomi R ^a   Glisson, Bonnie S ^a   Kies, Merrill S ^a   Myers, Jeffrey N ^a   Ang, K Kian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Unit 97   (United States)

Author keywords

Concurrent chemoradiation; Head and neck carcinoma; Locoregional control; Oropharyngeal carcinoma

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; CISPLATIN; FLUOROURACIL; ISOTRETINOIN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NECK DISSECTION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TONSILLECTOMY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 1542344364     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20069     Document Type: Article

References (27)

1. Fletcher GH, Goepfert H. Larynx and hypopharynx. In: Fletcher GH, editor. Textbook of radiotherapy. Philadelphia: Lea & Febiger, 1980:330-363.
2. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88:876-883.
3. Brizel DM, Albers MF, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
4. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
5. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
6. Fleming ID, Cooper JS, Hensen DE, et al., editors. AJCC cancer staging manual (5th edition). Philadelphia: Lippincott-Raven, 1998.
7. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
8. Wong CS, Ang KK, Fletcher GH, et al. Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1989;16:657-662.
9. Mak AC, Morrison WH, Garden AS, Ang KK, Goepfert H, Peters LJ. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys. 1995;33:289-296.
10. Weber RS, Peters LJ, Wolf P, Guillamondegui O. Squamous cell carcinoma of the soft palate, uvula, and anterior faucial pillar. Otolaryngol Head Neck Surg. 1988;99:16-23.
11. Weber RS, Gidley P, Morrison WH, et al. Treatment selection for carcinoma of the base of the tongue. Am J Surg. 1990;160:415-419.
12. Remmler D, Medina JE, Byers RM, Meoz R, Pfalzgraf K. Treatment of choice for squamous carcinoma of the tonsillar fossa. Head Neck Surg. 1985;7:206-211.
13. Gwozdz JT, Morrison WH, Garden AS, Weber RS, Ang KK, Peters LJ. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1997;39:125-135.
14. Piccirillo JF. Purposes, problems, and proposal for progress in cancer staging. Arch Otolaryngol Head Neck Surg. 1995;121:145-149.
15. Lydiatt WM, Shah JP, Hoffman HT. AJCC stage groupings for head and neck cancer: should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck. 2001;23:607-612.
16. Carinci F, Pelucchi S, Farina A, Calearo C. A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer. J Oral Maxillofac Surg. 1998;56:832-836.
17. Groome PA, Schulze KM, Mackillop WJ, et al. A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer. 2001;92:1484-1494.
18. Hart AA, Mak-Kregar S, Hilgers FJ, et al. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in the Netherlands. Cancer. 1995;75:2656-2662.
19. Pugliano FA, Piccirillo JF, Zequeira MR, et al. Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol Head Neck Surg. 1997;123:1118-1124.
20. Snyderman CH, Wagner RL. Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg. 1995;112:691-694.
21. Hall SF, Groome PA, Rothwell D, Dixon PF. Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck. Head Neck. 1999;21:30-38.
22. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110:593-602.
23. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 1996;77:1905-1911.
24. Lydiatt WM, Schantz SP. Biological staging of head and neck cancer and its role in developing effective treatment strategies. Cancer Metastasis Rev. 1996;15:11-25.
25. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx. A radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813.
26. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88:890-899.
27. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23:705-713.